 VANCOUVER and MINNEAPOLIS, April 16, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- Neovasc Inc. Neovasc or the Company NASDAQ , TSX : NVCN, today announced that the Tiara Transapical system Tiara TA will be unable to receive a European CE mark under the current Medical Device Directive regulations MDD ending on May 26, 2021. The Company is collaborating with its European Notified Body the Notified Body on potential next steps. 